Amylyx Pharmaceuticals, Inc. (AMLX) › Weighted Average Diluted SharesAmylyx Pharmaceuticals, Inc. (AMLX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 6.59M2022-12-31: 58.50M2023-12-31: 69.99M2024-12-31: 68.14M2025-12-31: 94.57M94.57M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3194.57M+38.8%2026-03-03From 2025-01-012024-12-3168.14M-2.6%2026-03-03From 2024-01-012023-12-3169.99M+19.7%2025-03-04From 2023-01-012022-12-3158.50M+788.1%2024-02-22From 2022-01-012021-12-316.59M—2024-02-22From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)